🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

AI-generated images threaten science — here’s how researchers hope to spot them nature.com/articles/d4158…

Huge congratulations to the OCR stars at this year’s Gala Case Comp Cancer Ctr Director Gary Schwartz, MD, and Sandy Markowitz, MD, PhD, on their awards from Ohio Cancer Research #CancerResearchSavesLives

Registration is open for Case CCC's Cancer Disparities Symposium! Join us March 6-7, 2025, for two days of presentations and group discussions about the successes and future directions of clinical trials. Learn more and register to attend at case.edu/cancer/events/….

Don’t miss this fantastic CME event featuring Adrian Seth Lindsey MetroHealth and the legend himself Bill Carey Cleveland Clinic We will be discussing all aspects of MASLD/MASH including epidemiology, diagnosis as well as current and potential future treatments! #livertwitter

Providing reliable, evidence-based cancer information is essential to building trust in science and #CancerCare—and importantly, improving health outcomes. Thanks to National Comprehensive Cancer Network (NCCN) for inviting me to speak about this important topic at the Patient Advocacy Summit. go.nih.gov/8MIehXY

Marcus Freeman making history 💯

Amazing experience at the new grantee workshop so far. Looking forward to continuing connecting with others. Cancer is tough, but we try to fight back together. Thank you National Cancer Institute @NCICancerBio for organizing this and Dr. Kimryn Rathmell Dr. Rathmell for the empowering talk.

I was delighted to meet with @NCICancerBio grant recipients this week – the work you’re all doing to advance understanding about the complexities of cancer is cutting-edge, paving the way for groundbreaking discoveries that will save lives.

Thank you @NCICancerBio for organizing this event even during the government holiday. Pumped to do more exciting work and write more grants

Most viewed in the last 7 days from JAMA Oncology: Individuals with a negative colonoscopy screening may not need a repeat exam for at least 20 years, according to a study of ~200,000 participants followed for up to 32 years. ja.ma/4abDiO6

Happening tomorrow! Don’t miss this fantastic comprehensive CME event and join the MASH conversation! CWRU-GI/Case Western GI Fellowship Cleveland Clinic IM MetroHealth Bianca Islam, MD, PhD Adrian Seth Lindsey @CLindenmeyerMD CCF GI Fellowship Jamak Modaresi @ JModaresi, MD Mark Abbott mousab tabbaa Scott Suckow

🚨 The 2025 American Cancer Society Cancer Statistics report is here! While cancer deaths dropped 34% since 1991 (4.5M lives saved), rising incidence in women, health disparities, and challenges in pancreatic cancer require urgent attention. Explore the stats: acsjournals.onlinelibrary.wiley.com/doi/full/10.33…

Sad....

Are you a medical student interested in oncology research? Apply today at bit.ly/SMT2025 for Case CCC's Summer Training for Medical Students Program!

Urgent progress needed: Pancreatic cancer remains the 3rd leading cause of cancer death in the US according to 2025 American Cancer Society report. Both incidence and mortality rates are rising, with a 5-year survival of just 8% for most patients. 🔗 acsjournals.onlinelibrary.wiley.com/doi/full/10.33… OncoAlert

Botensilimab with or without balstilimab in refractory MSS CRC with no liver metastases #ASCOGI25 🔎🗺️Phs-2 👉highest with 75 mg BOT / 240 mg BAL > 19% 👉BOT needs BAL 👉Acceptable safety 🧐Finally ICI in CRC? Supports planned phs-3 for combo ESMO - Eur. Oncology

Join us in congratulating Joe Sabik, MD, Chair of Department of Surgery, University Hospitals, on this exceptional and well-deserved honor.

We are honored to have received the renewal of our Comprehensive Cancer Center designation from National Cancer Institute. This important recognition allows us and our partners—CWRU School of Medicine, University Hospitals & Cleveland Clinic—to fund innovative cancer research that saves lives. case.edu/cancer/about-u…

Thank you @NCICancerBio for highlighting our work and for the kind support all these years, from my career grant and now the R37.

🚨 NEOPAN - Pancreatic Cancer Update 🚨 In LAPC (locally advanced pancreatic cancer) 🧬: 📊 Trial compared FOLFIRINOX vs Gemcitabine 👥 171 patients, PS ≤1, unresectable cases 📌 Primary endpoint: PFS 📌 Secondary endpoints: OS, QoL, safety 🧪 Results: 🕒 Median PFS: ➡️